New Biotech Offering Targets $426B Rare Disease Market

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

What's Going On With AI tokens?

Mark de Wolf
September 19, 2025

Crypto thrives on fads. Each fresh technology – NFTs, SocialFi, metaverse tokens – sparks furious rallies, only to see them slump when reality bites. This year's craze has been "DeFAI": artificial-intelligence agents designed to navigate decentralized finance.

In January, names like Virtuals and Ai16z sent tokens soaring. At one point the market value of AI-agent coins neared $16bn. Eight months later, they have shed nearly a third of their worth, even as Wall Street hits records on the back of AI-infrastructure spending. To many observers, the episode looks like another bout of speculative self-delusion. Yet it may also be a prelude to something more lasting.

White-labelled and re-skinned

The first generation of DeFAI projects promised sweeping automation. Platforms such as Virtuals' G.A.M.E. or Ai16z's ElizaOS made it easier to spin up tokenized agents able, in theory, to trade, lend or invest on behalf of their owners. Launchpads like DAOS.fun dangled visions of decentralized hedge funds: investors would pool cash, agents would manage it, and profits would flow back to token holders.

The idea was exciting. For little more than a few clicks, one could dispatch tireless digital workers to scour markets and place bets round the clock. An April survey by CoinGecko found that half of respondents believed AI would outperform humans at trading; one in seven was willing to hand over their portfolio entirely.

Reality proved more prosaic. Most offerings turned out to be thin wrappers around generic large-language models. Grand roadmaps led mainly to chatbots on Telegram or Discord. Tokens collapsed by over 90% from their December peak, and many treasuries soon ran dry. As in past crypto busts, investors discovered that clever tokenomics could not make up for missing utility.

Agents of change

The second wave of projects has adopted a more modest, and arguably more promising, approach. Instead of "do-it-all" bots, they focus on specialized tools that can work together.

Wayfinder exemplifies the shift. Its agents handle specific on-chain tasks--from cross-chain swaps to more elaborate strategies such as leveraged dollar-cost averaging--using embedded wallets. The system resembles a hive, each agent focused on a narrow role but orchestrated towards a wider goal.

HeyAnon takes a retail-friendly tack. Users can instruct it by voice ("Sell 0.2 ETH on Coinbase") and it will carry out the trade. That lowers the technical barrier that keeps many newcomers from experimenting with DeFi.

Virtuals Protocol aims to build standards for agent-to-agent commerce. Its Agent Commerce Protocol (ACP) would let bots communicate and delegate, multiplying their capabilities. The vision is less of a solitary super-agent and more of an agentic members club: specialized, collaborative, and self-improving with experience.

The promise, and the pitfalls

The potential prize is worth fighting for. Bitwise, a crypto asset manager, reckons that blending AI and blockchain could add $20trn to global GDP by 2030. In the near term, advocates point to agent-to-agent commerce as the most enticing application. Imagine an investment agent hiring a data-analysis agent, which in turn consults a risk-model agent before deciding whether to place a trade--all continuously, cheaply and without human oversight.

Such visions raise thorny questions. How much autonomy should these bots wield? Who ensures they follow financial regulations? How can digital assets entrusted to them be safeguarded? Without credible standards of trust, security and compliance, DeFAI's latest iteration could go the way of its predecessors.

The take away

Crypto has heard this song before. Smart contracts were once dismissed as arcane playthings; decentralized exchanges as impenetrable. Both are now pillars of DeFi. Early manias often mask genuine breakthroughs, their utility revealed only after the froth subsides.

DeFAI's evolving story is scarcely eight months old. Act one was defined by overblown ambition; act two is more practical, with agents honing in on specific tasks and working in concert. Whether they evolve into reliable robo-managers or fade into the compost heap of past crypto fads will depend less on hype than on whether they can solve real problems at scale.

For now, DeFAI's flame is flickering. But it may yet kindle something more enduring.

Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.

Continue Reading...

Popular

Donald Trump Orders Release of Amelia Earhart Files Nearly 90 Years After Her Disappearance

President Trump has declared his intention to declassify and make public all government records pertaining to the disappearance of aviation pioneer Amelia Earhart,

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

12 Communication Services Stocks Moving In Friday's After-Market Session

Gainers LQR House (NASDAQ: YHC) stock increased by 13.8% to $0.92 during Friday's after-market session. The market value of their outstanding shares is at $8.4 million. Moving iMage Technologies (AMEX:MITQ) stock increased by 7.44% to $1.01.

British department store Harrods warns customers that some personal details taken in data breach

LONDON (AP) — Harrods, the luxury British department store, has warned some customers that their personal data may have been taken in a breach of its online systems.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

AT&T attributes mass 911 outages in 3 states to fiber cuts made by 'third parties'

JACKSON, Miss. (AP) — Mass that swept across parts of Mississippi, Louisiana and Alabama on Thursday afternoon were caused by fiber cuts made by “third parties," according to a statement from AT&T.

FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects

Top health officials under Kennedy are pushing for more transparency on Covid vaccine risks, focusing on pregnant women and child deaths, amid disputes with GOP lawmakers and industry leaders.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Meta expected to unveil new smart glasses at Connect event

Meta is expected to show off artificial intelligence-powered smart glasses at its Connect developer conference Wednesday as CEO Mark Zuckerberg continues to evangelize the glasses as the next step in human-computer interactions.

Republicans unveil a bill to fund the government through Nov. 21. Democrats call it partisan

WASHINGTON (AP) — House Republicans unveiled Tuesday a stopgap spending bill that would keep federal agencies funded through Nov. 21, daring Democrats to block it knowing that the fallout would likely be a partial government shutdown that would begin Oct. 1, the start of the new budget year.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

US Attorney Erik Siebert Resigns After Refusing Trump Pressure To Pursue Criminal Case Against NY AG Letitia James: Report

U.S. Attorney Erik Siebert resigned after refusing Trump administration pressure to charge New York AG Letitia James without evidence, a move critics call political retribution.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Oracle Surges Over 3% In Pre-Market Amid TikTok Deal Speculation, AI Infrastructure Momentum

Oracle's stock continues to rise, driven by the potential TikTok acquisition and strong AI infrastructure positioning, with a 81.31% gain in 2025.

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

US jobless aid applications retreat to 231,000 after surging to nearly 4-year high a week earlier

The number of Americans applying for jobless aid last week retreated significantly after surging to a nearly four-year high a week earlier.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Bloom Energy Is Not Jim Cramer's 'Cup Of Tea,' But It's Going Up

Mad Money's Jim Cramer takes a look at QXO, Bloom Energy, Newmont, AllianceBernstein, Lam Research, LoanDepot and Centrus Energy.

Denmark leads an exercise in Greenland, with Russia in mind at a time of tensions with the US

NUUK, Greenland (AP) — Denmark is leading a military exercise with hundreds of troops from several European NATO members in Greenland, a maneuver that coincides with over the Trump administration's desire for U.S. jurisdiction over the vast Arctic territory.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

Benzinga Bulls And Bears: Oracle, Costco, NIO — And Wall Street Snaps Its Slide

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Zelenskyy calls for a European air defense system as Russian strike wounds 20 in Ukrainian city

KYIV, Ukraine (AP) — Russian forces bombarded the southern Ukrainian city of Zaporizhzhia with rockets overnight, wounding 20 people, including four children, President Volodymyr Zelenskyy said Tuesday as he urged European leaders to make the continent safe by building an ambitious air defense umbrella.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Datavault AI Shares Are Trending After New Initiative To Boost XRP Adoption: What You Should Know

Datavault AI Inc. (NASDAQ:DVLT) shares cooled down Tuesday after-hours following a solid double-digit surge in the regular trading session. The stock was seen trending at the time of writing.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Adobe Q3 Preview: Stock Has Slumped After 8 Of Last 9 Reports

A look at the earnings estimates for Adobe and key items to watch when the company reports Q3 results Sept. 11, 2025.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

Tennessee Governor Deploying Federal Agents and National Guard to Memphis

Tennessee will surge federal agents, deputized Guard, and $100M in support to Memphis, launching a multi-agency task force to combat violent crime.

Larry Summers Warns Trump's Push To Scrap Quarterly Earnings Will Affect How Markets Function: 'Students Don't Like Grades…'

Former Treasury Secretary Lawrence H. Summers warned that Donald Trump's proposal to eliminate quarterly earnings reports would weaken accountability and make markets "function less well."

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Kevin O'Leary Once Admitted He Wasn't The Best Dad — But The Shark Gave Himself A '10 Out Of 10' Score In One Key Area

Kevin O'Leary admitted he wasn't always present as a father but said financial stability made him a "10 out of 10" provider, sharing how tough-love lessons with his son and sacrifices echoed by Barack Obama and Mark Cuban highlight the trade-offs between family and success.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service